Business Wire

Sandoz and Pear Therapeutics Announce US Launch of reSET-O™ to Help Treat Opioid Use Disorder

BOSTON--(BUSINESS WIRE)--Sandoz Inc., a Novartis division, and Pear Therapeutics, Inc., announced today the US commercial launch of reSET-O™ for patients with Opioid Use Disorder (OUD). reSET-O, ...
La Opinión

Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced ...
Business Wire

Pear Therapeutics and Serve You Rx Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® and People with Substance and Opioid Use Disorders

Serve You Rx teams with Pear to lead access to prescription digital therapeutics (PDTs) with proven outcomes in treating substance use disorder (SUD) and opioid use disorder (OUD) and to support ...
Nasdaq

Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today ...
MobiHealthNews

Pear's reSET-O DTx lowers costs, enhances quality of life in new study

Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years compared with normal treatment alone. Treatment as usual was ...
MobiHealthNews

Pear's reSET-O for opioid use disorder saves payers $2,150 per patient, real-world claims review finds

A recently published review of real-world claims data suggests that opioid use disorder patients prescribed Pear Therapeutics' reSET-O digital therapeutic, alongside pharmacotherapy, had fewer ...
Nasdaq

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List

BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...
MedCity News

Opioid addiction app from Novartis and Pear Therapuetics gets FDA nod

The opioid epidemic has reached critical proportions in the United States, with more than 115 people dying from opioid overdose every day. In response to a crisis created by pharmaceuticals, some ...
Business Insider

Sandoz And Pear Announce US Launch Of ReSET-O To Treat Opioid Use Disorder

(RTTNews) - Sandoz Inc., a Novartis division, and Pear Therapeutics, Inc., announced the US commercial launch of reSET-O for patients with Opioid Use Disorder or OUD. reSET-O, cleared by the US Food ...
BioWorld

Data shows Pear’s Reset-O significantly reduces health care utilization in patients with opioid use disorder

Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...